---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-015714"
form_type: "8-K"
ticker: "XFOR"
cik: "0001501697"
company_name: "X4 Pharmaceuticals, Inc"
filed_at: "2023-05-04T23:59:59+00:00"
generated_at: "2026-06-15T21:41:53.313375+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "low"
source: SEC EDGAR
---

# X4 Pharmaceuticals posts updated corporate presentation on its website

## Summary
- Presentation posted May 4, 2023 on X4 Pharma's investor website.
- No specific financial, clinical, or operational updates disclosed in the filing.
- Presentation content and changes not detailed; investors directed to website.

## SEC filing metadata
- accession: 0001628280-23-015714
- form_type: 8-K
- ticker: XFOR
- cik: 0001501697
- company_name: X4 Pharmaceuticals, Inc
- filed_at: 2023-05-04T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: low
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1501697/000162828023015714/0001628280-23-015714-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1501697/000162828023015714/xfor-20230504.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-015714
- JSON: https://secwatch.observer/filing/0001628280-23-015714.json
- Plain text: https://secwatch.observer/filing/0001628280-23-015714.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.